Endocrine Society Advocacy Win: Congress Increases FY 2026 NIH Funding
The United States Congress has finalized and passed a comprehensive funding bill for the Department of Health and Human Services…
Disease Prevention & Management
Amara Maple The Endocrine Society Launches Rare Endocrine Disease Fellows Program to Address Critical Gaps in Specialized Medical Training and Patient Care
The Endocrine Society has officially announced the commencement of its Rare Endocrine Disease (RED) Fellows Program, a comprehensive educational initiative…
Eli Lilly Announces Pivotal Phase 3 Success for Orforglipron as Oral GLP-1 Agonist Demonstrates Superiority in Global Diabetes Trials
In a landmark development for the treatment of type 2 diabetes and metabolic health, Eli Lilly and Company has announced…
New Research Challenges Fears of Semaglutide-Linked Thyroid Cancer Risk
The study provides a detailed roadmap of how semaglutide interacts with the tumor microenvironment (TME), specifically targeting immune cells known…
Advances in Incretin-Based Therapies: Transformative Research and Real-World Challenges in Obesity and Cardiovascular Care
In observance of American Heart Month this February, the medical community is intensifying its focus on the intersection of metabolic…
The Cardiovascular Impact of GLP-1 Receptor Agonists New Research Insights into Tirzepatide and Comparative Efficacy in Type 2 Diabetes Management
As the pharmaceutical landscape undergoes a seismic shift driven by the proliferation of anti-obesity and glucose-lowering medications, the medical community…
The Endocrine Society Bolsters Global Scientific Research Through Expanded Funding Mentorship and Publishing Initiatives
In a strategic move to address the growing financial and professional challenges facing the global scientific community, the Endocrine Society…
Advancing Neuroendocrinology: Dr. Maria Andrea Camilletti on the Evolution of Pituitary Research and the Potential of Stem Cell Modeling
The field of neuroendocrinology is currently undergoing a transformative shift as researchers move beyond traditional observational studies toward sophisticated molecular…
Side Effects: Endocrine Society Journals Look at GLP-1RAs and the Positive and Negative Unintended Impacts
The pharmaceutical landscape is currently witnessing a paradigm shift as glucagon-like peptide-1 receptor agonists (GLP-1RAs), once specialized tools for glycemic…
Samuel Klein MD Named 2026 Endocrine Society Laureate for Transformative Research into Obesity and Metabolic Health
The Endocrine Society has officially announced that Samuel Klein, MD, the William H. Danforth Professor of Medicine and Nutritional Science…